From Cooperative to Opportunistic Federalism: Reflections on the Half-Century Anniversary of the Commission on Intergovernmental Relations von Conlan, Tim

Volltext

Federalism in a Time of Coronavirus: The Trump Administration, Intergovernmental Relations, and the Fraying Social Compact von Daguerre, Anne, Conlan, Tim

Volltext

Administration and Governance in a Compound Republic: Martha Derthick's Contributions to the Study of American Federalism von Conlan, Tim

Volltext

Federalism, the Bush Administration, and the Transformation of American Conservatism von Conlan, Tim, Dinan, John

Volltext

US federalism and the Bush administration von Conlan, Tim, Dinan, John, Allard, Scott W, Wong, Kenneth, Sunderman, Gail, Derthick, Martha, Benton, J Edwin, Posner, Paul, Rabe, Barry, Zimmerman, Joseph F, Krane, Dale, Milkis, Sidney M, Rhodes, Jesse H

Volltext

Factors influencing long‐term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib von Brümmendorf, Tim H., Cortes, Jorge E., Khoury, Hanna J., Kantarjian, Hagop M., Kim, Dong‐Wook, Schafhausen, Philippe, Conlan, Maureen G., Shapiro, Mark, Turnbull, Kathleen, Leip, Eric, Gambacorti‐Passerini, Carlo, Lipton, Jeff H.

Volltext

A RAGE-Targeted Antibody-Drug Conjugate: Surface Plasmon Resonance as a Platform for Accelerating Effective ADC Design and Development von Healey, Gareth D, Frostell, Asa, Fagge, Tim, Gonzalez, Deyarina, Conlan, R Steven

Volltext

A genome catalog of the early-life human skin microbiome von Shen, Zeyang, Robert, Lukian, Stolpman, Milan, Che, You, Allen, Katrina J, Saffery, Richard, Walsh, Audrey, Young, Angela, Eckert, Jana, Deming, Clay, Chen, Qiong, Conlan, Sean, Laky, Karen, Li, Jenny Min, Chatman, Lindsay, Kashaf, Sara Saheb, Kong, Heidi H, Frischmeyer-Guerrerio, Pamela A, Perrett, Kirsten P, Segre, Julia A

Volltext

Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer von Healey, Gareth D., Pan-Castillo, Belen, Garcia-Parra, Jezabel, Davies, Julia, Roberts, Shaun, Jones, Eilir, Dhar, Kalyan, Nandanan, Sarika, Tofazzal, Nasima, Piggott, Luke, Clarkson, Richard, Seaton, Gillian, Frostell, Asa, Fagge, Tim, McKee, Colin, Margarit, Lavinia, Conlan, R. Steven, Gonzalez, Deyarina

Volltext

Match High-Speed Running Distances Are Often Suppressed After Return From Hamstring Strain Injury in Professional Footballers von Whiteley, Rodney, Massey, Andrew, Gabbett, Tim, Blanch, Peter, Cameron, Matthew, Conlan, Greta, Ford, Matthew, Williams, Morgan

Volltext

Randomized Trial of Reamed and Unreamed Intramedullary Nailing of Tibial Shaft Fractures von Bhandari, Mohit, Guyatt, Gordon, Tornetta, 3rd, Paul, Schemitsch, Emil H, Swiontkowski, Marc, Sanders, David, Walter, Stephen D

Volltext

Patterning of Antibodies Using Flexographic Printing von Phillips, Christopher O, Govindarajan, Sridhar, Hamblyn, Simon M, Conlan, R. Steven, Gethin, David T, Claypole, Tim C

Volltext

Effects of chemotherapy on quality of life in breast cancer survivors von Wandell, Kaitlin K., Lustberg, Maryam B., Reinbolt, Raquel E., Orchard, Tonya, Andridge, Rebecca, Wandell, Hayley, Schade, Carly, Moran, Tim, Yang, Nan, Conlan, Trisha

Volltext

Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Failure With Imatinib Plus Dasatinib and/Or Nilotinib: 36-Month Update von Cortes, Jorge E., Khoury, H. Jean, Kantarjian, Hagop M., Lipton, Jeff H., Kim, Dong-Wook, Conlan, Maureen G., Leip, Eric, Turnbull, Kathleen, Brümmendorf, Tim H., Gambacorti-Passerini, Carlo

Volltext

Assessment Of Early Cytogenetic Response By 3 Months Versus >3-6 Months Or No Response By 6 Months As a Predictor Of Long-Term Clinical Outcomes In a Phase 1/2 Study Of Bosutinib I... von Cortes, Jorge E., Khoury, H. Jean, Hochhaus, Andreas, Apperley, Jane F, O'Brien, Stephen G., Leip, Eric, Turnbull, Kathleen, Conlan, Maureen G., Kantarjian, Hagop M., Brümmendorf, Tim H.

Volltext

Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Resistance Or Intolerance To Imatinib: 48-Month Update von Brümmendorf, Tim H., Cortes, Jorge E., Khoury, H. Jean, Kantarjian, Hagop M., Kim, Dong-Wook, Conlan, Maureen G., Leip, Eric, Turnbull, Kathleen, Gambacorti-Passerini, Carlo, Lipton, Jeff H.

Volltext

Long-term evaluation of vascular toxicity in patients with Ph+ leukemias treated with bosutinib von Cortes, Jorge E., Kantarjian, Hagop M., Khoury, Hanna Jean, Brümmendorf, Tim H., Conlan, Maureen G., Wang, Kongming, Fly, Kolette D., Shapiro, Mark, Lipton, Jeffrey Howard, Durand, Jean-Bernard, Gambacorti-Passerini, Carlo

Volltext

Long-term Results of Ponatinib in CP-CML: 4-Year Minimum Follow-up of a Phase 1 Trial von Kantarjian, Hagop M, Talpaz, Moshe, Cortes, Jorge E, Shah, Neil P, Bixby, Dale L, Flinn, Ian W, O’Hare, Thomas J, Hu, Simin, Rivera, Victor M, Clackson, Tim, Conlan, Maureen G, Haluska, Frank G, Druker, Brian J, Deininger, Michael W, Mauro, Michael J

Volltext

Appendix_Figure_2_Pre-Post_HSR_Means – Supplemental material for Match High-Speed Running Distances Are Often Suppressed After Return From Hamstring Strain Injury in Professional F... von Whiteley, Rodney, Massey, Andrew, Gabbett, Tim, Blanch, Peter, Cameron, Matthew, Conlan, Greta, Ford, Matthew, Williams, Morgan

Volltext bestellen

Appendix_Figure_1_Individual_cumulative_high_speed_running_distances – Supplemental material for Match High-Speed Running Distances Are Often Suppressed After Return From Hamstring... von Whiteley, Rodney, Massey, Andrew, Gabbett, Tim, Blanch, Peter, Cameron, Matthew, Conlan, Greta, Ford, Matthew, Williams, Morgan

Volltext bestellen